Quintiles Medical Development (Shanghai) Co Ltd is a wholly owned subsidiary of Quintiles Transnational Corp. - the leading clinical research organization in the world.
Quintiles China has been operating for more than a decade with two offices in China’s major cities of Beijing and Shanghai. It provides a range of services from monitoring Phase II-IV clinical trials to marketing and selling drugs in every major therapeutic area, such as Clinical monitoring and site management, Central labs, Project management, Commercialisation services, Regulatory services.
Quintiles Hong Kong has been in operation since 1996, providing expert clinical services and innovative
commercial solutions for our customers. Its office houses highly trained clinical monitors and project managers. Quintiles Austria offers Clinical Monitoring and Site Management, Medical and Scientific Services, Project management, Regulatory Services.
Quintiles Transnational Corp
Quintiles Transnational Corp. helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Quintiles helps its customers compress the time it takes to bring a drug from discovery through regulatory approval; accelerate the launch of products to peak sales, build effective sales forces and manage product portfolios more efficiently; and achieve strategic and financial objectives by offering tailored alternatives to traditional fee-for-service product development and commercial services agreements. Headquartered near Research Triangle Park, North Carolina, Quintiles was founded in 1982 and has more than 16,000 employees and offices in over 50 countries.
Quintiles opened an office in Shanghai in 1998, the center of China's burgeoning pharmaceutical and biotechnology industries.
Quintiles' network of laboratories covers one of the broadest geographic areas in the industry with owned facilities in the U.S., Europe, South Africa and Singapore, operational offices in South America and China and sub-contract facilities in China, Brazil, Argentina and Australia.